Chronic Neutrophilic Leukemia with V617F JAK2 Mutation
- First Online:
- Cite this article as:
- Gajendra, S., Gupta, R., Chandgothia, M. et al. Indian J Hematol Blood Transfus (2014) 30: 139. doi:10.1007/s12288-012-0203-6
- 118 Downloads
Chronic neutrophilic leukemia (CNL) is a rare disease grouped under World health organization classification as chronic myeloproliferative disease. It is a diagnosis of exclusion in patients with sustained mature neutrophilia and splenomegaly with no evidence of other myeloproliferative disease or reactive neutrophilia. V617F JAK 2 mutation has been described in classical myeloproliferative diseases, but its association with CNL has been reported in a few cases. Here in, we describe three cases of CNL with presence of V617F JAK 2 mutation. To distinguish CNL from secondary neutrophilia can be difficult. Detection of the V617F JAK 2 mutation in such scenario can provide a useful diagnostic test to establish the neoplastic nature of the neutrophilia.